Zenith LifeScience LLC
H-1B Sponsorship & Salary Data — Government-Verified
$111,249Avg. Salary
22Filings
15+Job Titles
December 2025Last Filing
According to TheRealSalaries.com analysis of official US Department of Labor filings (October 2024 - December 2025), Zenith LifeScience LLC pays a median H-1B salary of $95,680 — 21% below the national median of $121,514. Based on 22 certified Labor Condition Applications.
Section 1
What does Zenith LifeScience LLC pay?
Zenith LifeScience LLC's H-1B filings show an average salary of $111,249 based on 22 certified LCA applications. Salaries range from $71,760 to $176,800.
$111,249
Average
$95,680
Median
$71,760
Minimum
$176,800
Maximum
Recent H-1B Filings
| Job Title | Salary |
|---|---|
| Manager, PV Standards Quality Training and Compliance | $125,000 |
| Scientist II | $93,600 |
| Scientist II | $93,600 |
| Project Manager | $104,000 |
| Specialist Clinical Study Management | $72,800 |
| Scientist II | $93,600 |
| Patient Safety Specialist | $79,040 |
| Associate Scientist Bioscience | $71,760 |
| Specialist Clinical Study Manager | $87,360 |
| GPV Case Management Product Specialist | $99,840 |
| Sr. Clinical Research Associate (CRA) | $176,800 |
| Sr. Clinical Research Associate (CRA) | $176,800 |
| Senior Clinical Research Associate | $166,400 |
| Regulatory Affairs Specialist | $80,000 |
| Specialist Clinical Study Management | $95,680 |
| Clinical Research Associate | $120,000 |
| Pharmacovigilance (PV) Submission Specialist | $104,000 |
| Drug Safety Specialist | $80,000 |
| Clinical Trial Master File Specialist | $80,000 |
| Clinical Trial Master File Specialist | $144,560 |
| Clinical Trial Master File Specialist | $144,560 |
| Clinical Trial Master File Specialist | $158,080 |
Section 2
States with Zenith LifeScience LLC H-1B Filings
Similar Companies
Section 3
All salaries above must meet the Department of Labor's wage floor — see how the H-1B prevailing wage levels work, or browse all sponsor companies.
Source: US Department of Labor LCA Disclosure Data. Last updated: Q1 FY2025.